5 results
EPA-0672 – Efficacy Outcomes in Age and Sex Subgroups from two Clinical Trials of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-1407 – The First European Studies of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-deficit/hyperactivity Disorder
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- HTML
- Export citation
EPA-0993 – Health Utility Scores in Children and Adolescents with Attention-deficit/Hyperactivity Disorder: Response to Stimulant Treatment
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-0994 – Assessing Adhd Stimulant Treatment Efficacy Using the Weiss Functional Impairment Rating Scale: Strengths and Weaknesses
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-0719 – Post Hoc Analyses on the Efficacy of Lisdexamfetamine Dimesylate Following Previous Treatment with Attention Deficit/Hyperactivity Disorder Medication
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation